Zealand Pharma A/S
ZLDPF
$40.99
-$0.01-0.02%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 982.34M | 999.84M | 1.02B | -170.39M | -156.38M |
| Total Depreciation and Amortization | 3.64M | 3.42M | 3.20M | 3.24M | 3.36M |
| Total Amortization of Deferred Charges | 3.18M | 2.36M | 2.36M | 2.36M | 2.36M |
| Total Other Non-Cash Items | -12.50M | 171.12M | 149.88M | -661.80K | -1.35M |
| Change in Net Operating Assets | 16.55M | -46.79M | -23.40M | -7.87M | 16.76M |
| Cash from Operations | 993.20M | 1.13B | 1.16B | -173.33M | -135.26M |
| Capital Expenditure | -5.08M | -2.63M | -2.09M | -1.85M | -1.45M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -261.10K | -261.10K | -261.10K | 3.33M | -- |
| Other Investing Activities | -348.09M | -267.02M | -1.03B | -797.48M | -1.07B |
| Cash from Investing | -353.44M | -269.91M | -1.03B | -796.00M | -1.07B |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 369.87M |
| Total Debt Repaid | -20.16M | -18.77M | -17.53M | -16.92M | -16.44M |
| Issuance of Common Stock | 49.15M | 32.61M | 35.82M | 7.05B | 8.52B |
| Repurchase of Common Stock | -407.17M | -407.17M | -603.21M | -351.83M | -351.83M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00K | -2.46M | -213.63M | -236.58M |
| Cash from Financing | -57.83M | -60.15M | -88.00M | 932.17M | 1.20B |
| Foreign Exchange rate Adjustments | -7.78M | -8.73M | -25.65M | -46.20K | 892.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 574.16M | 791.16M | 11.22M | -37.21M | -11.80M |